These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 65790)

  • 1. In vitro platelet stain preventing (degranulating) effect of various substances, Study of mechanism of action.
    Stavem P; Kjaerheim A
    Scand J Haematol; 1977 Feb; 18(2):170-6. PubMed ID: 65790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregometry and anti-platelet isoantibodies.
    Pogliani E; Deliliers GL; Ferrari R; Pozzoli E; CoFrancesco E; Praga C
    Haemostasis; 1975; 4(1):23-35. PubMed ID: 172412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of scanning electron microscopy to study structural-functional relationships in normal and diseased platelets.
    Mattson JC
    Scan Electron Microsc; 1985; (Pt 1):357-91. PubMed ID: 3890145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
    Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
    Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of anticoagulants on the activation of platelets ex vivo.
    Schneider DJ; Tracy PB; Mann KG; Sobel BE
    Circulation; 1997 Nov; 96(9):2877-83. PubMed ID: 9386152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
    Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
    Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological changes of platelets during the process of platelet aggregation in gray platelet syndrome.
    Mori K; Suzuki S; Sugai K; Akutsu Y; Ishikawa M; Sakai H
    Tohoku J Exp Med; 1986 Aug; 149(4):425-36. PubMed ID: 3775766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "New" platelet diseases and their biochemical aspects.
    De Gaetano G
    Acta Vitaminol Enzymol; 1973; 27(5):223-32. PubMed ID: 4596641
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine - an antiplatelet drug: effects in human volunteers.
    O'Brien JR; Etherington MD; Shuttleworth RD
    Thromb Res; 1978 Aug; 13(2):245-54. PubMed ID: 694843
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of aggregating agents and their inhibitors on the mean platelet shape.
    O'Brien JR; Heywood JB
    J Clin Pathol; 1966 Mar; 19(2):148-53. PubMed ID: 4956138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation and release reaction in normal and abnormal platelets.
    Cronberg S
    Acta Univ Carol Med Monogr; 1972; 53():75-7. PubMed ID: 4670757
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of aggregation inducers and inhibitors on the functional properties and the ultrastructure of platelets].
    Lakin KM; Makarow WA; Mular AG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):849-52. PubMed ID: 94877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of platelets and concanavalin A.
    Kaplan KL; Nachman RL
    Thromb Res; 1975 Dec; 7(6):847-59. PubMed ID: 1198553
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the significance of the influx of calcium ions into stimulated human blood platelets.
    Massini P; Lüscher EF
    Biochim Biophys Acta; 1976 Jul; 436(3):652-63. PubMed ID: 821527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on platelet protein phosphorylation in patients with impaired responses to platelet agonists.
    Speiser-Ellerton S; Weiss HJ
    J Lab Clin Med; 1990 Jan; 115(1):104-11. PubMed ID: 2105365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A macromolecular serum component acting on platelets in the presence of EDTA--platelet stain preventing factor?
    Stavem P; Berg K
    Scand J Haematol; 1973; 10(3):202-8. PubMed ID: 4129256
    [No Abstract]   [Full Text] [Related]  

  • 20. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.
    Lages B; Weiss HJ
    Thromb Haemost; 1981 Apr; 45(2):173-9. PubMed ID: 6789496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.